Skip to main content

NL
FR
EN

Other information and services: www.belgium.be Logo of the Belgian Federal Authorities

Your medicine and health products

About the FAMHP
Jobs
Publications
Press
Contact
Complaints
Webportal

Search

Home
Human use
Veterinary use
Information for the public
Information for professionals

Home
Veterinary use
Medicines
Current Page:Medicines

Medicines

Scientific-Technical Advice
Research & Development
- Clinical trials
Marketing Authorisation procedures
Pharmacovigilance
Production
Distribution & delivery
Authorisation - Certificates
Declarations
- Medicines for export
- Manufacturing activity as a sub-contractor
Proper use

Last updated on 16/12/2020

Notification of adverse reactions or incidents

PIL and SPC
of a medicine

(PIL: patient information leaflet SPC: summary of product characteristics)

News

13/10/2021

PRAC October 2021 – Nomegestrol containing products and chlormadinone containing products and update on COVID-19 vaccines

11/10/2021

Veterinarian? Register now for the online information session on the new European legislation on veterinary medicines on 22 October 2021

07/10/2021

Modified invoicing for applications for national scientific-technical advice

28/09/2021

Register now for the online information session on the new European veterinary medicines legislation on 15 October 2021

© 2016 - FAMHP

Ponvory (Janssen-Cilag)
Sarclisa®
Sarclisa®
olipudase alfa
olipudase alfa
olipudase alfa
Tebentafusp
Tebentafusp
Tebentafusp
Norditropin®
202110
202110
Disclaimer

instructions how to enable JavaScript in your web browser